Spots Global Cancer Trial Database for comparator: adacel™ (concomitant)
Every month we try and update this database with for comparator: adacel™ (concomitant) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) | NCT00988884 | Human Papilloma... | V503 Comparator: Men... Comparator: Ada... Comparator: Men... Comparator: Ada... | 11 Years - 15 Years | Merck Sharp & Dohme LLC | |
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) | NCT00325130 | Neoplasms, Glan... Diphtheria Tetanus Whooping Cough Meningitis | Comparator: Qua... Comparator: Men... Comparator: Ada... Comparator: Men... Comparator: Ada... | 11 Years - 17 Years | Merck Sharp & Dohme LLC |